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Abstract 
Scope 
The use of biomarkers in the objective assessment of dietary intake is a high priority in nutrition 
research. The aim of this study was to examine pentadecanoic acid (C15:0) and heptadecanoic acid 
(C17:0) as biomarkers of dairy foods intake. 
Methods and results 
The data used in the present study were obtained as part of the Food4me Study. Estimates of C15:0 
and C17:0 from dried blood spots and intakes of dairy from an FFQ were obtained from participants 
(n=1,180) across 7 countries. Regression analyses were used to explore associations of biomarkers 
with dairy intake levels and receiver operating characteristic (ROC) analyses were used to evaluate 
the fatty acids. Significant positive associations were found between C15:0 and total intakes of high-
fat dairy products. C15:0 showed good ability to distinguish between low and high consumers of 
high-fat dairy products. 
Conclusion 
C15:0 can be used as a biomarker of high-fat dairy intake and of specific high-fat dairy products. 
Both C15:0 and C17:0 performed poorly for total dairy intake highlighting the need for caution when 
using these in epidemiological studies.  
 
 
Graphical abstract: 
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The study explored the association between C15:0 and C17:0 levels in dried-blood spots and intake 
of dairy, including high-fat and low-fat dairy products.  
 
 
 
 
Introduction 
Adequate measurement of dietary intake is crucial to health-related research as much of the public 
health burden in both industrialised and developing societies is due to chronic diseases associated 
with lifestyle factors, notably poor diet quality and excess energy intake [1, 2]. However, research on 
dietary exposures relies on self-reported methods, such as food frequency questionnaires, food 
diaries and 24-hour recalls, that are susceptible to random and systematic measurement errors, 
including recall bias and energy under-reporting [3]. Mis-classification of individuals’ dietary intakes 
resulting from these errors may contribute to inconsistencies in diet-disease outcomes in published 
nutritional epidemiological studies [4]. Given these limitations, interest has grown in the 
identification and use of biomarkers as more objective assessment methods of food intake [2]. The 
development, validation and application of novel biomarkers of food intake are particularly 
pertinent for those foods where associations with important health outcomes are poorly understood 
or subject to controversy. One such example is dairy products for which improved measurement of 
www.mnf-journal.com Page 4 Molecular Nutrition & Food Research 
 
 
This article is protected by copyright. All rights reserved. 
4 
 
intake would help to clarify inconsistent findings about the relationships between intake of dairy 
foods and cardiovascular health [5] and to strengthen the evidence for links between dairy products 
and the risk of metabolic syndrome and type 2 diabetes [6, 7].    
The odd-chain length saturated fatty acids pentadecanoic acid (C15:0) and heptadecanoic acid 
(C17:0) have been proposed as potential biomarkers of dairy intake. The available evidence from 
observational studies suggests that C15:0 may be a good biomarker of long-term dairy fat intake [8, 
10-12]. Relationships between dairy fat intake and C15:0 levels in adipose tissue and blood lipid 
fractions have been similar with correlations ranging from 0.74 to 0.45 for adipose tissue samples 
and from 0.50 to 0.45 in serum or plasma lipid fractions [12, 13]. Levels of C15:0 in plasma and 
adipose tissue are also significantly associated with reported consumption of dairy and dairy 
products, such as whole milk, butter and ice cream; with correlations ranging from 0.28 to 0.22 for 
total dairy products between 0.21 and 0.13 for butter, and between 0.27 and 0.17 for cheese [6, 11, 
13-15]. Levels of C17:0 in adipose tissue, serum cholesterol esters and phospholipids have also been 
reported to be associated with dairy fat intake, but less so with dairy product intake. Reported 
correlations between dairy fat intake and C17:0 in adipose tissue, serum cholesterol esters and 
phospholipids are in the range of 0.30 to 0.16 [12]; between 0.13 and 0.11 for dairy fat and plasma 
lipid fractions [15]; and between 0.24 and 0.16 for dairy product intake and adipose tissue samples 
[10, 16]. More recently, a randomized controlled trial conducted with a free-living Canadian 
population found a significant increase in plasma levels of C15:0 and of C17:0 following a 4-week 
intervention with 3 servings of dairy products daily (low fat milk -1% fat, low fat yoghurt -1.5% fat, 
and cheese - 34% fat) [17].    
Levels of C15:0 and C17:0 in plasma phospholipids, cholesteryl esters, total plasma lipids, 
erythrocytes, triacylglycerol, and subcutaneous adipose tissue from the buttock or abdomen have 
been explored as biomarkers of dairy foods intake [11-13, 15, 19]. In addition, Baylin et al. [20] found 
that whole blood levels of C15:0 and C17:0 reflected dietary intake of these fatty acids. Given that 
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the collection of whole blood samples as dried blood spots (DBS) is a technically relatively easy and 
cost efficient method, there is interest in assessing their use for the measurement of dietary intake 
biomarkers, including biomarkers of dairy products intake.  
The objective of this study is to examine blood levels of C15:0 and C17:0 measured in DBS as 
potential biomarkers of dairy product intake in a large multicultural cohort of European adults.  
 
 
 
Materials and methods 
Study sample 
Data for the study were sourced from the Food4Me Proof of Principle study, a randomized 
controlled trial of personalised nutrition among European adults. The study ran from August 2012 to 
February 2014 and included participants from Germany, Greece, Ireland, the Netherlands, Poland, 
Spain and the UK. Participants were recruited through local advertising directing them to the project 
website (http://www.food4me.org/). Local recruitment sites were University College Dublin 
(Ireland); Maastricht University (the Netherlands); University of Navarra (Spain); Harokopio 
University (Greece); University of Reading (United Kingdom; UK); National Food and Nutrition 
Institute (Poland); Technische Universität München (Germany). A screening questionnaire excluded 
interested individuals who reported being pregnant, having food intolerances or allergies, having 
chronic disease (e.g. diabetes), or being on a therapeutic diet. A full description of the study protocol 
and screened participants has been previously published [21, 22]. The Research Ethics Committees 
at each University or Research Centre delivering the intervention granted ethical approval for the 
study. The Food4Me trial was additionally registered as a Randomized Clinical Trial (NCT01530139) 
at Clinicaltrials.gov. All participants provided informed consent. 
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Of 1607 individuals randomised to the intervention, 1,471 observations on blood fatty acid levels 
and dairy foods intake at baseline (“Month 0”) were initially included in this study. After exclusion of 
participants (n=262) with under- or over-reporting of energy intake (see below), and accounting for 
missing values for C15:0 and C17:0 levels (n=29), the final sample consisted of 1,180 observations.  
Measurements 
Participants provided finger-prick blood samples through two DBS cards (Vitas Ltd, Oslo, Norway; 
DSM N.V., Heerlen, Netherlands) providing approximately 5 drops of blood (150µl) per card [21]. 
Participants were instructed to let the blood spots dry at room temperature for at least 2 hours but 
for no more than 4 hours. One of the DBS samples was sent by post using the collection pack 
provided to the corresponding recruitment centre, and from there to Vitas (Vitas Ltd, Norway) for 
measurement of whole blood fatty acids. Very briefly, punches of dried human whole blood were 
removed from the DBS sample and directly methylated with 0.5 M sodium methoxide. After 
incubation at 50 ⁰C for 20 minutes, the formed fatty acid methyl esters (FAMES) were extracted into 
hexane and analysed on a Agilent Technologies GC-FID. The fatty acid methyl esters were separated 
on a Supelco SP2380 (30m x 250µm x 0.2µm) column and reported as g/100 gram FAME. Theoretical 
response factors were used for all fatty acids except for EPA, DPA and DHA. For these PUFAs, a USP 
FAME mixture was used to calculated empirical response factors within each sequence. Whole blood 
samples stored as DBS were used as quality control samples (QC). Two QCs were run in each 
sequence, one at the beginning and one at the end.  CV% for the estimation of C15:0 and C17:0 were 
4.3% and 4.9%, respectively. BMI was estimated as kg/m2 using participants’ online self-reported 
body weight and height. 
Assessment of dietary intake 
Habitual food intake over the previous month was assessed using an on-line Food Frequency 
Questionnaire (FFQ) with 157 food items specifically developed for the Food4Me intervention and 
validated against the printed EPIC-Norfolk FFQ (version CAMB/PQ/6/1205) [23, 24]. Bland Altman 
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analysis showed good agreement between these two FFQs for intake of dairy food groups. 
Correlations analysis also revealed good agreement with coefficients varying from 0.55 (milk) to 0.77 
(yogurts). Validity of the FFQ against a 4-day weighed food record (n=49) showed good agreement 
for dairy food groups with correlation coefficients ranging from 0.46 (cheese) to 0.73 (yogurt). [25].  
Under-reporting of energy intake was determined from the comparison of total reported energy 
intake against the lowest estimated energy requirement (1.1 times the predicted basal metabolic 
rate [26]). Over-reporting of total energy intake was defined as values exceeding 18.84 MJ/day.   
Statistical analyses 
Normality was explored through Shapiro-Wilk tests of normality and quantile-quantile plots. Means, 
medians, standard deviations, and inter-quartile ranges were calculated to explore demographic 
characteristics of the participants, variation in dairy product intake and blood levels of fatty acids, in 
the whole cohort and also according to country of recruitment. Differences between countries were 
explored using Kruskal-Wallis equality-of-populations rank tests with post-hoc pairwise comparisons 
for continuous variables, and logistic regression analyses for categorical variables (overall mean as 
reference group). Differences by sex in the pooled sample and within countries were tested using 
the Wilcoxon rank-sum non-parametric test for two independent samples.  
Separate ordinary least square (OLS) regression analyses were used to examine the independent 
association between each dairy product intake category (total dairy, high-fat dairy, low-fat dairy, 
cheese) as the dependent variable, and the log-transformed C15:0 or C17:0 levels as the 
independent variable. For variables with large proportions of reported zero consumption (milk: 12%, 
cream: 48%, yoghurt: 12%, butter: 42%, and zero-fat milk: 69%), associations were analysed using a 
corner-solution Tobit model with left-censoring at zero [27: 595]. For outcomes that tend to pile up 
at specific values (e.g. zero), this type of model provides more appropriate estimates of the 
conditional mean of the outcome variable because it accounts for the fact that, under such 
conditions, there is not a linear relationship with the explanatory variables [27: 668]. All regressions 
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included total energy intake as an independent covariate. Four specifications were explored: an 
“unadjusted” model including only the fatty acid and total energy; a “basic” model, including age, 
age squared and sex; an “adjusted” model additionally including smoking status and standardized 
BMI, and a “full” model incorporating all of the previous covariates and a set of individual country 
variables with value 1 if an observation was from a particular country and 0 otherwise.  
Robust standard errors (Huber-White) were used to address heteroskedasticity in the data. 
Estimated coefficients of interest included the β values for the OLS regressions, and the marginal 
effects for Tobit models estimated at the sample mean of the fatty acid independent variable. 
Calculated this way, Tobit marginal effects have a similar interpretation to OLS coefficients [27: 599].   
ROC curves were used to assess the sensitivity and specificity of blood levels of C15:0 and C17:0 as 
biomarkers of intake of dairy products. Parameters from a ROC analysis give an indication of the 
biomarker’s ability to correctly classify subjects given an observed binary outcome (e.g. positive vs. 
negative). The area under the curve (AUC) estimates the probability that a randomly selected 
positive outcome will have a higher “classifier” or biomarker value than a randomly selected 
negative outcome [28] and can be used to evaluate the “classification performance” of biomarkers 
[29]. According to the AUC value, the discriminating ability of biomarkers of can be broadly classified 
as excellent (AUC>0.90), good (0.8 < AUC < 0.9), fair (0.7< AUC < 0.8) and poor (AUC < 0.70) [28]. 
ROC analyses compared the ability of the log-transformed C15:0 and C17:0 levels to discriminate 
individuals in the 10th percentile of intake and above the 90th percentile if intake. Details of the cut-
offs of intake for each dairy product category analysed are given in the Supporting Information 
(Table A3). The curve tester facility of the online ROC Curve Explorer and Tester tool (ROCCET, 
http//www.roccet.ca) [28] was used for the ROC curve analyses. STATA Software version 13.0 [30] 
was used for all other analyses. p-values (two-sided) of ≤0.05 were considered evidence of statistical 
significance.  
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Results 
Data from 1,180 participants (39% males) with an average (± sd) age of 40 ± 13 years (18 to 73 years) 
were analysed. The average BMI was 25.2 ± 4.8 kg/m2 and waist circumference was 84.8 ± 13.3 cm 
(Table 1). The mean total energy intake was 10.6 MJ/day± 6.4 MJ/day, with dairy products supplying 
on average 12.5 ± 6.4 % of this energy. Along with Germany, Poland had one of the highest values 
for % energy intake from dairy (13.7 ± 7.4 %; 14.1 ± 6.7 %, respectively) and % of total fat from dairy 
(18.8 ± 9 %). Other differences were observed for proportion of smokers in the sample, in mean total 
energy intake, and in average total fat intake (Table 1). 
Dairy products intake 
The median (± interquartile range) intake of dairy products was 304.4 ± 279.6 g/day (Table 2). The 
median intake of low-fat dairy products was almost 14-fold higher than that of high-fat dairy 
products (251 g/day vs. 18.6 g/day). Across product categories, milk had the highest median intake 
per day (177.7 ± 266.6 g/day), followed by yoghurt (53.6 ± 94.9 g/day) and cheese (24.4 ± 36.3 
g/day).  
Countries differed in their levels of dairy intake (Table 2). Median (± interquartile range) intake of 
high-fat dairy products was highest in Germany (35.7 ± 30.8 g/day) and lowest in Spain (11.1 ± 13.7 
g/day), while Greece had the lowest intake of both low-fat (197.2 ± 230 g/day) and total dairy 
products (237.8 ± 285.3 g/day) across all countries. Approximately half of the Spanish and Greek 
participants reported no consumption of butter and cream, while Germans and Polish participants 
had median intakes of 6.4 ± 13.3 g/day and 3.9 ± 11.5 g/day respectively. The median intakes of the 
other categories of dairy products are reported in Table 2. 
Within countries, Greek and Irish women had significantly (p < 0.05) lower intakes of butter than did 
men (Table A.1, Supporting Information), whereas Irish and UK women had higher median intakes of 
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yoghurt than did men (53.6 g/day vs. 17.9 g/day; and 53.6 g/day vs. 24.5 g/day, respectively). 
Women also reported higher consumption than men of cream in Germany (4.3 g/day vs. 3.0 g/day). 
C17:0 and C15:0 levels in dried blood spots   
Across the entire sample, the average (± sd) level (expressed as % composition total fatty acids) of 
C17:0 was 0.32 ± 0.06 %, and that of C15:0 was 0.20 ± 0.06 % (Table 3). These values are in good 
agreement with previously reported values for adipose tissue and serum [31]. Overall, the Pearson 
correlation coefficient between C15:0 and C17:0 was 0.57 (0.55 for the logged variables). 
The lowest mean levels of C15:0 were in Spain (0.16 ± 0.04 %, p < 0.05) and Greece (0.19 ± 0.05 %, p 
< 0.05), and the highest in Germany (0.24 ± 0.06 %, p < 0.05). The highest levels of C17:0 were in 
Germany and Poland (0.33%, p < 0.05), but were otherwise similar across countries. Men and 
women differed significantly in their average levels of C15:0 (0.19% vs. 0.20%, p < 0.05) and of C17:0 
(0.32% vs. 0.31%, p < 0.05) (Table A.2, Supporting Information). By country, levels of C15:0 between 
men and women were significantly different only in Poland, where women had higher levels than 
men (0.23% vs 0.19%, p < 0.05). In contrast, there were more sex differences in C17:0 levels within 
countries (lower for women in Ireland, Germany and the Netherlands, and higher in Poland) (Table 
A.2, Supporting Information).  
Associations of blood levels of C15:0 and C17:0 with dairy intake 
Levels of C15:0 and of C17:0 were positively and significantly associated (p < 0.001) with intakes of 
total dairy, high-fat dairy, and low-fat dairy (Table 4). These associations remained significant after 
adjusting for age, sex, smoking status, BMI and country (full model). C15:0 had stronger associations 
with intakes across all the different dairy product categories compared to C17:0 (full model, 
standardized coefficients). The largest difference was found for high-fat dairy, with the coefficient 
for C15:0 almost double the value of that of C17:0. In contrast, levels of C17:0 showed no association 
with intake of zero-fat milk, and levels of C15:0 showed a negative association with consumption of 
zero-fat milk that was not significant after adjusting for the full set of controls (Table 4). 
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Unadjusted regressions showed strongly significant (p < 0.001) positive associations between C15:0 
and intake levels of cream, yoghurt, cheese and butter; and between C17:0 levels and intake of 
cheese and butter. Unadjusted regressions also showed significant positive associations of C17:0 
levels with milk (p = 0.003) and with yoghurt (p = 0.01), and of C15:0 levels with total milk 
consumption (p = 0.007). This pattern of associations remained after controlling for age, sex, BMI, 
smoking status and country of origin. The largest independent associations (adjusting for all factors) 
were mostly observed for C15:0, particularly for butter (standardized beta = 0.27) and cheese 
(standardized beta = 0.19). These higher-fat products also showed the largest difference between 
C15:0 and C17:0 coefficient values (Table 5). Robustness checks adjusting for alcohol, ruminant meat 
and fish showed no change in results.  
ROC analyses showed that C15:0 levels provided acceptable predictability for discriminating 
between low and high consumers of high-fat dairy (AUC=0.84; 95% CI: 0.79, 0.89); while levels of 
C17:0 had low AUC values for total, high-fat and low-fat dairy products (AUCs < 0.69) (Figure 1). The 
combined C15:0 and C17:0 model did not improve the AUCs over the results obtained for C15:0 
alone.  
By product category, C15:0, but not C17:0, showed good to fair discriminating ability when 
comparing low consumers and high consumers of butter (AUC=0.80; 95% CI: 0.76, 0.83), low and 
high consumers of cheese (AUC=0.72, 95% CI: 0.66, 0.78), and low consumers and high consumers of 
cream (AUC=0.66, 95% CI: 0.61, 0.71) (Figure 2). The joint model showed little improvement from 
the individual C15:0 models. In contrast, the AUC values for the  food products  with lower dairy fat 
content of yoghurt and milk showed very low predictability for both C15:0 and C17:0 (AUCs < 0.60) 
(Figure A.1, Supporting Information).   
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Discussion 
The present study demonstrated the potential utility of C15:0 and C17:0 levels measured in DBS as 
biomarkers of intakes of dairy products in European adults across 7 countries. C15:0 levels were 
significantly associated with intakes of high-fat dairy products. However, both fatty acids performed 
poorly as biomarkers of total dairy intake highlighting that caution should be exercised when using 
such markers as measures of total dairy intake in epidemiological studies.  
Previous studies looking into biomarkers of dairy have found correlations of plasma C15:0 with 
measures of intake of total dairy, high-fat dairy, low-fat dairy, cheese, butter and full-fat milk [6, 13-
15]. This study also found associations of C15:0 with high-fat dairy, low-fat dairy, butter and cheese; 
and additionally with total cream, total yoghurt and total milk consumption. Moreover, after 
controlling for potential confounding factors, including country of origin, the largest associations 
were observed for high-fat dairy, butter, and cheese. Additional analyses using ROC curves showed 
that levels of C15:0 did not distinguish well between low consumers and high consumers of total and 
low-fat dairy. In contrast, levels of C15:0 classified low and high consumers of high-fat dairy, butter, 
cheese and cream reasonably well; corroborating findings from the regression analyses and 
providing further evidence of the potential role of C15:0 as a biomarker for high-fat dairy intake.  
Results also demonstrated positive associations for blood levels of C17:0 and dairy intake. With the 
exception of total cream, significant associations were found for all three dairy product categories 
(total, high-fat and low-fat dairy) and all the individual product groups examined here. Previous 
studies evaluating the levels of C17:0 in blood lipid fractions have also found positive correlations of 
C17:0 with total dairy intake levels, but generally of a lower magnitude than those reported for 
C15:0 [15, 18, 32]. Observed associations of C17:0 with dairy intake levels were also lower than 
those for C15:0 in this study, across all the dairy categories. ROC curves also mostly reflected the 
weaker relationships of C17:0 with dairy intake levels. Lower associations for blood levels of C17:0 
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may be reflecting other metabolic processes associated with this fatty acid in addition to dietary 
sources [16].  
Results across the linear regressions and the ROC curves showed that C15:0 and C17:0 performed 
better for high-fat dairy products compared to lower-fat dairy products (e.g. milk, yoghurt). Different 
levels of saturated fatty acids per unit of dairy product may explain the relatively stronger 
associations of blood C15:0 and C17:0 levels with high-fat dairy. For example, dietary estimates of 
C15:0 in Norway indicated much lower relative levels of this fatty acid in skimmed milk compared 
with full fat milk [19]. The strong results for high-fat dairy in this study may also reflect the fact that 
milk was not included in this category during analyses, given previous findings of a lack of association 
of plasma C15:0 with milk intake, and accompanying suggestions that this lack of relationship is 
owing to the fact that milk fat may be metabolized differently than fats from other dairy products 
[19]. 
 Strengths of this study include the use of a large sample of dietary patterns and blood lipid levels 
across seven European countries, allowing more information to be extracted from the data than 
would be the case with typical small-sample biomarker studies [33]. The use of ROC analyses to 
explore the ability of C15:0 and C17:0 to correctly classify high and low consumers of dairy provided 
greater insight into the performance of these fatty acids as biomarkers of intake compared to more 
conventional correlation techniques [32], and is another important contribution of this study. Finally 
this study highlights the use of DBS for collection of samples and analysis of diet related biomarkers: 
use of this approach in large longitudinal cohort studies could represent an inexpensive method for 
assessing diet related parameters. Work from others has demonstrated the stability of the markers 
and the use of this DBS approach in measuring a range of other fatty acids including n-3 poly-
unsaturated fatty acids which are related to oily fish consumption [34, 35]. Limitations to consider 
when evaluating the results of the study are the possibility that, although data used in this study was 
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from a purposely-designed and validated FFQ questionnaire [24, 25], the strength of observed 
associations may have been attenuated by the use of this instrument for dietary data collection [19].  
In conclusion, C15:0 measured in DBS performed well as a biomarker of high-fat dairy intake only. 
Overall findings highlight the utility of this biomarker for dietary assessment of high-fat dairy and, 
ultimately, for improved understanding through epidemiological studies of the role of diets high in 
dairy fat and in specific dairy products in the development of cardiovascular disease [36]. Moreover, 
recent findings of a negative association of high blood levels of C15:0 and C17:0 with type 2 diabetes 
[37, 38] indicate the potential of these fatty acids to act as biomarkers when studying diet-disease 
relationships. However, caution needs to be exerted when interpreting these biomarkers as 
indicators of food intake: the present data clearly demonstrates stronger relationships with high fat 
dairy products. Finally, the results extend the evidence base for the use of DBS in measuring dietary 
biomarkers and their potential application in large-scale epidemiological studies of nutrition and 
health. 
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Tables 
Table 1. Sample demographic and anthropometric characteristics from 1,180 respondents 
across Germany, Greece, Ireland, the Netherlands, Poland, Spain and the UK. 
 
Total Germany Greece Ireland Nether. Poland Spain UK 
 (n=1180) (n=172) (n=154) (n=187) (n=183) (n=157) (n=173) (n=154) 
Men (%) 39.3 44.8 35.1 38.0 49.2 27.4 46.8 31.2 
  
        
Age (years) 40.3 43.8 38.5 39.2 43.6 35.8 42.2 37.7 
  (13.0) (13.5) (11.2) (12.7) (14.5) (12.2) (10.6) (13.3) 
  
        
Smoking (%) 12.1 5.8 35.7 6.4 5.5 9.6 19.1 5.2 
  
        
BMI (kg/m2) 25.2 24.5 26.9 25.3 24.6 24.5 26.1 24.8 
  (4.8) (3.9) (6.5) (4.8) (4.4) (4.9) (4.1) (4.4) 
  
        
Waist circumference 
(cm) 
84.8 85.0 88.3 84.8 85.3 80.9 86.9 82.1 
  (13.3) (13.5) (14.7) (13.4) (12.6) (13.7) (12.3) (11.5) 
  
        
Total energy intake 
(MJ/day) 
10.6 10.6 9.6 11.1 11.4 10.3 10.9 10.4 
  (3.1) (2.6) (3.2) (2.8) (3.0) (3.4) (3.1) (3.1) 
  
        
Energy intake from 
dairy (%) 
12.5 14.1 12.3 10.9 12.9 13.7 11.6 11.8 
  (6.4) (6.7) (6.8) (5.1) (6.4) (7.4) (6.6) (5.1) 
  
        
Total energy from fat 
(%) 
35.8 37.1 37.6 36.4 34.5 34.8 35.5 35.1 
  (5.8) (5.1) (6.6) (5.2) (6.0) (5.3) (5.9) (6.0) 
  
        
Total fat intake from 
dairy (%) 
16.5 18.8 16.8 14.6 18.8 17.9 14.0 14.7 
  (8.7) (9.0) (9.2) (7.1) (9.1) (9.5) (8.2) (6.6) 
Nether. = the Netherlands. Values are means with standard deviations in parentheses except for 
smoking status, which represents proportion of the sample that smokes.  
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Table 2. Mean, median and standard deviation of dairy intake (g/day) by product categories and 
country 
  
Total Germany Greece Ireland Nether. Poland Spain UK p1 
  (n=1180) (n=172) (n=154) (n=187) (n=183) (n=157) (n=173) (n=154)  
Total dairy         
Mean 360.9 334.7 290.7 336.9 383.4 394.8 409.4 373.4 0.0003 
  sd 269.4 216.5 266.5 204.1 295.4 312.3 318.8 238.5 
 
 Median 304.4 285.7 237.8 310.4 318.0 301.1 334.6 345.6 
 
  iqr 279.6 285.3 225.0 240.4 305.4 326.0 336.5 264.3 
 
High-fat dairy         
Mean 27.0 42.9 25.5 26.3 27.7 27.8 15.8 22.5 0.0001 
  sd 27.2 33.3 25.8 23.5 28.8 25.1 21.2 23.1 
 
Median 18.6 35.7 17.3 18.7 17.9 21.2 11.1 15.6 
 
  iqr 30.9 30.8 29.4 26.1 34.8 33.9 13.7 25.0 
 
 Low-fat dairy         
Mean 310.4 283.0 253.3 293.8 321.2 342.6 353.6 323.9 0.0013 
  sd 256.4 210.2 264.0 194.4 271.9 304.3 295.3 230.2 
 
 Median 251.8 240.8 197.2 280.1 262.5 241.1 272.4 305.6 
 
  iqr 271.5 290.5 230.0 212.4 321.2 300.6 294.9 259.3 
 
Milk         
Mean 213.7 185.1 187.5 223.9 191.5 202.2 252.1 254.2 0.0001 
  sd 227.6 184.6 249.1 169.2 229.2 262.8 266.9 213.1 
 
 Median 177.7 135.1 133.3 189.0 108.0 133.3 189.0 196.7 
 
  iqr 266.6 228.6 239.6 214.0 297.5 225.0 234.8 242.5 
 
 Cream          
Mean 2.6 6.4 1.7 1.1 2.0 4.0 1.4 1.8 0.0001 
  sd 6.0 12.5 2.5 2.1 3.2 6.2 2.2 2.7 
 
 Median 1.1 4.3 0.0 0.0 1.1 2.1 0.0 0.0 
 
  iqr 3.2 4.6 2.7 2.1 2.1 4.3 2.1 3.0 
 
 Yoghurt         
Mean 80.3 85.4 48.7 60.5 113.7 106.1 84.8 59.5 0.0001 
  sd 99.9 86.8 69.9 80.1 143.7 108.1 103.7 57.2 
 
Median 53.6 62.5 24.4 40.1 71.4 80.1 53.6 44.6 
 
  iqr 94.9 98.2 44.6 89.3 129.5 89.3 107.1 98.1 
 
 Cheese          
Mean 35.0 38.3 40.1 25.9 38.2 48.0 30.1 25.8 0.0001 
  sd 34.7 30.9 39.3 27.0 33.3 44.1 35.7 24.3 
 
Median 24.4 30.1 26.6 17.3 28.3 34.4 17.3 19.1 
 
  iqr 36.3 31.8 40.9 25.3 42.0 45.4 27.9 29.3 
 
 Butter         
Mean 5.8 11.3 0.7 8.7 3.3 10.1 1.2 5.0 0.0001 
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Total Germany Greece Ireland Nether. Poland Spain UK p1 
  (n=1180) (n=172) (n=154) (n=187) (n=183) (n=157) (n=173) (n=154)  
  sd 11.2 14.6 2.4 13.2 7.8 15.6 2.8 8.2 
 
Median 1.1 6.4 0.0 2.1 0.6 3.9 0.0 1.1 
 
  iqr 6.4 13.3 0.0 11.5 2.1 11.5 1.1 6.4 
 1p-value of test of differences across countries (Kruskal-Wallis test of difference across k 
independent samples). sd= standard deviation, iqr= interquartile range: difference between the third 
and first quartiles. High fat dairy includes double cream, high fat cheese, medium fat cheese and 
butter. Low fat dairy includes full fat or whole milk, low-fat or semi-skimmed milk, zero-fat or 
skimmed milk, single or sour cream, fruit yoghurt or fruit mousse, full fat Greek yoghurt, low-fat 
natural yoghurt, low-fat cheese, and very low-fat cheese. Milk: full-fat, semi-skimed and zero-fat 
milk. Cream: double/clotted cream and single cream. Yoghurt: full-fat/Greek yoghurt, low-fat 
yoghurt and fruit yoghurt/mousse. Cheese: high-fat (e.g. Stilton, Cheddar, Brie), medium-fat (e.g. 
Goats, Camembert, Feta, Emmental), low-fat (e.g. Fresh Mozzarella, Cream Cheese, Katiki) and very 
low-fat cheeses (e.g. Cottage Cheese, Quark). Nether. = the Netherlands. 
 
 
 
Table 3. Mean and standard deviation of C15:0 and C17:0 blood fatty acid levels  
 Total 
German
y 
Greece Ireland 
Nether
. 
Poland Spain UK 
 
 (n=1180
) 
(n-=172) 
(n=154
) 
(n=187
) 
(n=183
) 
(n=157
) 
(n=173
) 
(n=154
) 
p1 
Pentadecanoi
c (C15:0)          
Mean 0.20 
0.24 0.19 0.21 0.21 0.22 0.16 0.20 0.000
1 
sd 0.06 0.06 0.05 0.05 0.05 0.07 0.04 0.05 
 
Median 0.20 0.23 0.19 0.20 0.20 0.21 0.15 0.20  
iqr 0.07 0.08 0.05 0.06 0.06 0.07 0.05 0.06  
          
Heptadecanoi
c (C17:0)          
Mean 0.32 0.33 0.32 0.32 0.32 0.33 0.31 0.31 
0.000
1 
sd 0.06 0.07 0.05 0.05 0.05 0.06 0.05 0.05  
Median 0.32 0.32 0.32 0.32 0.32 0.33 0.30 0.31  
iqr 0.07 0.08 0.07 0.06 0.06 0.07 0.06 0.06  
1p-value of Kruskal-Wallis test of difference across k independent samples. sd= standard deviation, 
iqr= interquartile range: difference between the third and first quartiles. C15:0 and C17:0 blood fatty 
acid levels as percentage of total blood fatty acids. Nether. = the Netherlands. 
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Table 4. Associations of blood C15:0 and C17:0 levels and total dairy, high-fat dairy, low-fat 
dairy and zero-fat milk intake (g/day) 
 Total 
dairy 
  High
-fat 
dairy 
  Low-
fat 
dairy 
  Zero
-fat 
Milk
a 
  
 β
c 
se p-
valu
e 
β se p-
valu
e 
β se p-
valu
e 
β se p-
valu
e 
No 
adjustment 
            
Pentadecano
ic (C15:0)
b 
115.0
4 
(27.6
3) 
p < 
0.00
1 
31.9
9 
(3.00
) 
p < 
0.00
1 
101.6
3 
(27.1
1) 
p < 
0.00
1 
-
45.8
8 
(12.6
0) 
p < 
0.00
1 
 [0.12]   [0.32
] 
  [0.11]   [-
0.14] 
  
Heptadecan
oic (C17:0)
b 
186.0
0 
(43.7
8) 
p < 
0.00
1 
22.3
1 
(5.14
) 
p < 
0.00
1 
173.1
6 
(42.4
6) 
p < 
0.00
1 
-
13.9
2 
(18.1
0) 
0.44
3 
 [0.12]   [0.14
] 
  [0.11]   [-
0.03] 
  
             
Basic model             
Pentadecano
ic (C15:0) 
111.3
1 
(27.6
7) 
p < 
0.00
1 
31.7
5 
(3.00
) 
p < 
0.00
1 
98.74 (27.2
2) 
p < 
0.00
1 
-
49.4
8 
(12.4
8) 
p < 
0.00
1 
 [0.11]   [0.32
] 
  [0.11]   [-
0.15] 
  
Heptadecan
oic (C17:0) 
201.0
5 
(43.2
6) 
p < 
0.00
1 
22.8
9 
(5.15
) 
p < 
0.00
1 
183.7
4 
(42.4
5) 
p < 
0.00
1 
-8.14 (17.8
4) 
0.64
9 
 [0.13]   [0.14
] 
  [0.12]   [-
0.02] 
  
             
Adjusted 
model 
            
Pentadecano
ic (C15:0) 
104.8
9 
(28.5
3) 
p < 
0.00
1 
31.9
4 
(2.91
) 
p < 
0.00
1 
94.08 (28.0
8) 
0.00
1 
-
50.9
4 
(12.6
7) 
p < 
0.00
1 
 [0.11]   [0.32
] 
  [0.10]   [-
0.16] 
  
Heptadecan
oic (C17:0) 
194.0
6 
(45.1
8) 
p < 
0.00
1 
22.1
4 
(5.10
) 
p < 
0.00
1 
179.8
6 
(44.3
5) 
p < 
0.00
1 
-6.66 (18.0
3) 
0.71
2 
 [0.12]   [0.14
] 
  [0.12]   [-
0.01] 
  
             
Full model             
Pentadecano 167.3 (30.4 p < 25.3 (2.92 p < 151.2 (30.0 p < -8.91 (12.9 0.49
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ic (C15:0) 1 7) 0.00
1 
5 ) 0.00
1 
0 5) 0.00
1 
7) 4 
 [0.17]   [0.26
] 
  [0.16]   [-
0.03] 
  
Heptadecan
oic (C17:0) 
211.4
6 
(45.9
6) 
p < 
0.00
1 
18.0
8 
(4.95
) 
p < 
0.00
1 
192.3
5 
(45.3
5) 
p < 
0.00
1 
20.2
9 
(18.5
7) 
0.27
3 
 [0.13]   [0.11
] 
  [0.13]   [0.04
] 
  
a Marginal effects from a Tobit model for corner solutions. b Variable in logarithm. Standard errors in 
parentheses. c Regression coefficients. Standardized coefficients in brackets. Standardized 
coefficients show the standard deviation change in the dependent variable when the independent 
variable is changed by one standard deviation. Basic model: adjusted for age, age squared and sex. 
Adjusted model: variables in basic model and smoking status, standardized BMI. Full model: adjusted 
model covariates plus country indicator variables. All models adjusted for total energy intake 
(kcal/day). High fat dairy includes double cream, high fat cheese, medium fat cheese and butter. Low 
fat dairy includes full fat or whole milk, low-fat or semi-skimmed milk, zero-fat or skimmed milk, 
single or sour cream, fruit yoghurt or fruit mousse, full fat Greek yoghurt, low-fat natural yoghurt, 
low-fat cheese, and very low-fat cheese. 
 
 
 
Table 5. Associations of blood C15:0 and C17:0 levels and dairy product intake (g/day) 
  
Milk
a     
Crea
m
a     
Yogh
urt
a     
Che
ese 
    
Butt
er
a     
 β
c 
se 
p-
val
ue 
β se 
p-
val
ue 
β se 
p-
val
ue 
β se 
p-
val
ue 
β se 
p-
val
ue 
No 
adjustme
nt 
               
Pentadec
anoic 
(C15:0)
b 
54.
91 
(20.
49) 
0.0
07 
3.06 
(0.
76) 
p < 
0.0
01 
35.7
7 
(8.7
2) 
p < 
0.0
01 
24.1
4 
(3.
66) 
p < 
0.0
01 
12.0
0 
(1.
17) 
p < 
0.0
01 
 
[0.0
8] 
  
[0.2
0] 
  
[0.12
] 
  
[0.1
8] 
  
[0.3
9] 
  
Heptade
canoic 
(C17:0)
b 
97.
06 
(32.
71) 
0.0
03 
2.93 
(1.
60) 
0.0
67 
35.5
7 
(13.
87) 
0.0
10 
21.1
0 
(5.
63) 
p < 
0.0
01 
7.99 
(1.
65) 
p < 
0.0
01 
 
[0.0
8] 
  
[0.1
2] 
  
[0.07
] 
  
[0.1
0] 
  
[0.1
6] 
  
                
Basic 
model 
               
Pentadec
anoic 
(C15:0) 
54.
44 
(20.
67) 
0.0
08 
3.02 
(0.
76) 
p < 
0.0
01 
34.0
6 
(8.6
0) 
p < 
0.0
01 
23.2
8 
(3.
62) 
p < 
0.0
01 
11.9
7 
(1.
17) 
p < 
0.0
01 
 [0.0
8] 
  
[0.2
0] 
  
[0.11
] 
  
[0.1
8] 
  
[0.3
9] 
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Heptade
canoic 
(C17:0) 
102
.48 
(32.
78) 
0.0
02 
3.01 
(1.
57) 
0.0
56 
39.1
2 
(13.
83) 
0.0
05 
23.6
6 
(5.
69) 
p < 
0.0
01 
7.97 
(1.
62) 
p < 
0.0
01 
 
[0.0
9] 
  
[0.1
2] 
  
[0.08
] 
  
[0.1
2] 
  
[0.1
6] 
  
                
Adjusted 
model 
               
Pentadec
anoic 
(C15:0)
 
54.
60 
(21.
59) 
0.0
11 
2.92 
(0.
71) 
p < 
0.0
01 
29.5
8 
(8.7
1) 
0.0
01 
23.9
4 
(3.
52) 
p < 
0.0
01 
11.7
7 
(1.
15) 
p < 
0.0
01 
 [0.0
8] 
  
[0.1
9] 
  
[0.10
] 
  
[0.1
9] 
  
[0.3
8] 
  
Heptade
canoic 
(C17:0) 
104
.41 
(34.
54) 
0.0
03 
2.76 
(1.
46) 
0.0
59 
32.5
7 
(13.
57) 
0.0
16 
24.1
9 
(5.
73) 
p < 
0.0
01 
7.31 
(1.
65) 
p < 
0.0
01 
 
[0.0
9] 
  
[0.1
1] 
  
[0.07
] 
  
[0.1
2] 
  
[0.1
5] 
  
                
Full 
model 
               
Pentadec
anoic 
(C15:0) 
96.
56 
(22.
50) 
p < 
0.0
01 
1.46 
(0.
63) 
0.0
20 
35.1
2 
(9.3
4) 
p < 
0.0
01 
24.0
6 
(3.
69) 
p < 
0.0
01 
8.47 
(1.
11) 
p < 
0.0
01 
 [0.1
3] 
  
[0.1
0] 
  
[0.12
] 
  
[0.1
9] 
  
[0.2
7] 
  
Heptade
canoic 
(C17:0) 
108
.56 
(34.
57) 
0.0
02 
2.11 
(1.
37) 
0.1
25 
38.1
1 
(14.
13) 
0.0
07 
21.3
9 
(5.
56) 
p < 
0.0
01 
5.14 
(1.
52) 
0.0
01 
 [0.0
9] 
  
[0.0
9] 
  
[0.08
] 
  
[0.1
0] 
  
[0.1
0] 
  
a Marginal effects from a Tobit model for corner solutions. b Variable in logarithm. Standard errors in 
parentheses. c Regression coefficients. Standardized coefficients in brackets. Standardized 
coefficients show the standard deviation change in the dependent variable when the independent 
variable is changed by one standard deviation. Basic model adjusted for sex, age and age squared. 
Adjusted model expanded to include smoking status, and standardized BMI. Full model: adjusted 
model covariates plus country indicator variables. All models adjusted for total energy intake 
(kcal/day). 
Figure legends 
Figure 1. Receiver operating characteristic (ROC) curves for the discriminating power of 
C15:0, C17:0 by total dairy, high-fat dairy and low-fat dairy categories produced using single 
fatty acid models (top and middle panels) and a model containing both fatty acids 
simultaneously (bottom panel). The low and high consumers were selected using the 10th 
and 90th percentile. Details of the intake level cut-offs for low and high consumption are in 
Table A.3. The x axis represents the false positive rate (1- specificity), the y axis represents 
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the true positive rate (sensitivity). The red dot represents the mathematically optimal cut-
off point for classifying subjects into “positive” (high consumption) or “negative” (low 
consumption) outcomes.  
 
Figure 2. Receiver operating characteristic (ROC) curves for the discriminating power of 
C15:0, C17:0 by dairy product produced using single fatty acid models (top and middle 
panels) and a model containing both fatty acids simultaneously (bottom panel). The low and 
high consumers were selected using the 10th and 90th percentile. Details of the intake level 
cut-offs for low and high consumption are in Table A.3. The x axis represents the false 
positive rate (1- specificity), the y axis represents the true positive rate (sensitivity). The red 
dot represents the mathematically optimal cut-off point for classifying subjects into 
“positive” (high consumption) or “negative” (low consumption) outcomes.  
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